Effect of nembutal on LH release in baboons.

Regularly cycling female baboons were selected and maintained under a diurnal light schedule from 0500 to 1900 hr (CST). Beginning three days prior to the expected LH peak, blood was collected daily at 0800 and 1600 hr for 6 days in 5 baboons under light sedation for radioimmunoassay of plasma LH and estrogen. The plasma level of LH increased linearly and reached a peak in the afternoon of the second day. The peak in plasma estrogen appeared prior to the LH peak. In order to examine the critical period of LH surge in baboons, nembutal was injected daily at 1300 hr beginning a few days prior to expected LH relase. Initial dose of nembutal was 35 mg/kg body weight, but a supplementary dose was later required for a full 5 hours of anesthesia. Blood was collected at 1600 hr from 4 baboons during nembutal injections and after cessation of nembutal injections for radioimmunoassay of plasma LH and estrogen. It was found that nembutal injections suppressed LH release in 2 baboons, and caused a delay of LH release in 2 baboons. However, the plasma level of estrogen declined immediately after initiation of nembutal injection and remained lower. The evidence illustrates the nature of the neural components of LH release which became effective in the afternoon during the ovulatory phase. In addition, a linear increase in plasma level of LH, which is due to accumulation of circulating LH, is necessary for induction of ovulation in baboons.     

Dissolved DNA produced through a prey-predator relationship in a species-defined aquatic microcosm

Changes in concentration of dissolved DNA was studied in a species-defined microcosm consisting of bacteria Escherichia coli, protozoa Tetrahymena thermophila and algae Euglena gracilis. A marked increase in dissolved DNA was observed when T. thermophila grazed on E. coli and grew. This meant the prey–predatory relationship between E. coli and T. thermophila was responsible for the increase of dissolved DNA. This revised version was published online in September 2006 with corrections to the Cover Date.     

Dynamic Organization of Microtubules in Guard Cells of Viciafaba L. with Diurnal Cycle

Stomatal movement is regulated by changes in the volume of guardcells, thought to be mainly controlled by an osmo-regulatorysystem. In the present study, we examined the additional involvementof cytoskeletal events in the regulation of stomatal movement.Microtubules (MTs) in guard cells of Viciafaba L., grown undersunlight, were observed during the day and night by immunofluorescencemicroscopy. Cortical MTs began to be organized in a radial arrayat dawn and increased in numbers in the morning following theincrease in the stomatal aperture size. Thereafter, MTs becamelocalized near the nucleus and began to be destroyed from theevening to midnight, following the decrease in stomatal aperturesize. These diurnal changes in MT organization were observedeven two days after transfer from natural light condition tototal darkness, and were accompanied by corresponding changesin stomatal aperture. The increase in stomatal aperture sizein the early morning was inhibited by 50 µM propyzaraide,which destroys cortical MTs in guard cells, whereas the decreasein aperture size in the evening was suppressed by 10 µMtax-ol, which stabilizes cortical MTs. These results suggestthat radially-organized cortical MTs of guard cells may controldiurnal stomatal movement. (Received September 3, 1997; Accepted November 5, 1997)     

The Gene for Death Agonist BID Maps to the Region of Human 22q11.2 Duplicated in Cat Eye Syndrome Chromosomes and to Mouse Chromosome 6

Cat eye syndrome (CES) is associated with a duplication of a segment of human chromosome 22q11.2. Only one gene,ATP6E, has been previously mapped to this duplicated region. We now report the mapping of the human homologue of the apoptotic agonistBidto human chromosome 22 near locus D22S57 in the CES region. Dosage analysis demonstrated thatBIDis located just distal to the CES region critical for the majority of malformations associated with the syndrome (CESCR), as previously defined by a single patient with an unusual supernumerary chromosome. However,BIDremains a good candidate for involvement in CES-related mental impairment, and its overexpression may subtly add to the phenotype of CES patients. Our mapping of murineBidconfirms that the synteny of the CESCR and the 22q11 deletion syndrome critical region immediately telomeric on human chromosome 22 is not conserved in mice.Bidand adjacent geneAtp6ewere found to map to mousechromosome 6, while the region homologous to the DGSCR is known to map to mouse chromosome 16.     

Coronary stent implantation throughout technical evolution: immediate and follow-up results

Coronary stenting (stent implantation) has evolved over the last 5 years with changes in stent design, stent material and the implantation technique. The use of high-pressure balloon inflation (HP), intravascular ultrasound (IVUS) and appropriate antiplatelet therapy have contributed to the abolishment of the need for subsequent anticoagulation, allowing extended stent applications. We compared results in three groups of patients having stent implantation throughout the period of evolution: group A: no IVUS, no HP, with subsequent anticoagulation treatment (n 3 434); group B: no IVUS, yes HP, without subsequent anticoagulation treatment (n 3 192); and group C: yes IVUS, yes HP, without subsequent anticoagulation treatment (n 3 588). The primary success rates were comparable in all groups. There was a clear change in indications for stenting in groups B and C compared with group A (elective stenting: group A 3 32%; group B 3 66%; group C 3 69%; P < 0.0001), in reference vessel size (group A 3 3.22 3 0.37 mm; group B 3 2.92 3 0.56 mm; group C 3 2.98 3 0.57 mm; P < 0.0001), and for presence of type B2 and C lesions (group A 3 57%; group B 3 72%; group C 3 74%; P < 0.001). The complication rate significantly decreased in group C (group A 3 3.6%; group B 3 4.1%; group C 3 1.2%; P < 0.001) and the mean patient hospital stay decreased to 2 days in groups B and C due to the abolition of the need for anticoagulant treatment. The angiographic restenosis rate increased in groups B and C (group A 3 20%; group B 3 34%; group C 3 32%; P < 0.001). The need for a repeat procedure increased as stenting of more complex lesions and smaller vessels was attempted: target lesion revascularization (TLR) was performed in 16% of patients in group A (73/434), in 18% of group B (35/192) and in 22% of group C (129/588) (P 3 0.04 for A versus C). Major cardiac events (MACE) occurred in 142 patients in group A (33%), 60 patients in group B (31%) and in 181 patients in group C (30%). The evolving technique of coronary stenting has expanded the spectrum of indications and range of coronary vessels attempted, and decreased the complication rates and hospital stay. However, in less-favorable subsets, additional improvements are needed to affect the long-term outcome.     

High frequency of mutations at position 11778 in mitochondrial ND4 gene in Japanese families with Leber's hereditary optic neuropathy

We have investigated the presence of a point mutation at position 11778 in the ND4 gene of mitochondrial DNA in 17 Japanese families with Leber's hereditary optic neuropathy (LHON), and have identified the mutation in 14 (82.4%) of the 17 families. The prevalence of this mutation appears to be much higher in Japanese patients with LHON than in patients of other ethnic origins, such as Finnish, Dutch, German, and English families.     

Blockage of Nerve Growth Factor Action in PC12h Cells by Staurosporine, a Potent Protein Kinase Inhibitor

Staurosporine, which has a structure similar to that of K-252a, a potent protein kinase inhibitor that blocks nerve growth factor (NGF) action in PC12 and PC12h cells, is also known as a potent inhibitor of several protein kinases. This study shows that in PC12h cells staurosporine has a dual action: at lower concentrations than that required by K-252a, it is an inhibitor of NGF induction of neurite formation and of changes in the phosphorylation of specific proteins, whereas at concentrations higher than that required to inhibit NGF-induced neurite outgrowth, it rapidly enhances outgrowth by itself.     

Mechanisms of crown gall formation: T-DNA transfer fromAgrobacterium tumefaciens to plant cells

Agrobacterium tumefaciens harbouring the Ti plasmid incites crown gall tumor on dicotyledonous species. Upon infection of these plants, T-DNA in the Ti plasmid is transferred by unknown mechanisms to plant cells to be integrated into nuclear DNA. WhenAgrobacterium is incubated with protoplasts or seedlings of dicotyledonous plants, circulation of T-DNA and expression ofvir (virulence) genes on the Ti plasmid are induced. The circularization event is efficiently induced by mesophyll protoplasts of tobacco which are highly competent for transformation by the T-DNA, and is also induced by diffusible phenolic compounds excreted from the protoplasts. The circularization and formation of crown gall both require the expression of thevirD locus, one of the induciblevir genes. These results suggest that the circularization of T-DNA reflects one of steps of the T-DNA transfer during formation of crown gall. In contrast to dicotyledonous plants, monocotyledonous plants are thought to be unresponsive to infection byAgrobacterium. We showed that monocotyledonous plants do not excrete diffusible inducers for the expression ofvir genes, while they contain a novel type of a signal substance(s). This inducer is not detected in the exudates of seedlings of monocotyledonous plants, but is found in the extracts from the seedlings, and also those from the seeds, bran and germ of wheat and oats. This finding suggests that T-DNA processing, and possibly its transfer, should take place whenAgrobacterium invades seedlings and seeds of monocotyledonous plants. Recipient of the Botanical Society Award for Young Scientists, 1987.